Alto Neuroscience Inc.

NYSE: ANRO
Share price (9/9/25): $3.77
Market cap (9/9/25): $102 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Registration of securities for employees

Prospectus supplement with pricing info

Addition of securities to prior initial registration

Ownership Filter

Armistice Capital, LLC

Hanley Jr. Michael Conick

News Filter

Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Change in Directors, Officers or Compensation

Identifies Biomarker and Reports Positive Pharmacodynamic Results From Exploratory Phase 2 Proof-Of-Concept Trial of ALTO-203

Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash Runway

Reports First Quarter 2025 Financial Results and Recent Business Highlights

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

SEC STAFF LETTER